Just In
Don't Miss
- Finance
Buy, Sell Or Hold Stock Strategy Before Union Budget 2023
- Movies
Bigg Boss 16 | Tina Datta REACTS To What Cheap Thing Did Shalin Bhanot Ask Her To Give On The Show
- Automobiles
Pure EV ecoDryft Electric Motorcycle Launched At Rs 99,999 - 130km Range
- Education
Shiv Nadar University inviting Applications for UG Admissions 2023; Check Details Here
- Technology
Samsung Galaxy S23 To Opt For Cheaper Storage Tech: Is It A Mistake?
- News
To discuss Khalistani extremism, India calls on the Premier of Victoria
- Travel
Karli: A Great Excursion from Lonavala, Pune, Mumbai
- Sports
Hockey World Cup 2023: German resilience ends Belgian dominance, India's wait for elusive medal continues
India-Made Covaxin Now On UK's Approved Travel List
India's indigenously-made 'Covaxin', one of the vaccines being used nationwide in the inoculation campaign against the COVID-19 pandemic, is on the UK's list of approved COVID-19 vaccines for international travellers from Monday, November 22.
It will benefit more fully vaccinated Indians planning travel to the UK without the need for a pre-departure PCR test or self-isolation at the address declared on their compulsory Passenger Locator Forms.
Like other fully vaccinated travellers, including those vaccinated with Covishield, they are required to pre-book a PCR or Lateral Flow Test on arrival in England, to be taken before the end of day 2.
"From 4 am on Monday 22 November, the government will recognise vaccines on the World Health Organisation's Emergency Use Listing (WHO EUL) at the border," the UK's Department for Transport (DfT) confirmed.
"As a result, Sinovac, Sinopharm Beijing and Covaxin will be added to our existing list of approved vaccines for inbound travel, benefitting more fully vaccinated passengers," it said.
Earlier this month, the Bharat Biotech manufactured Covaxin - the second most used formulation in India - had received its WHO EUL status, resulting in the UK announced plans to include it on its list of approved Covid vaccines from November 22.
The WHO Emergency Use Listing process includes a review of the quality, safety and efficacy data performed by WHO experts and many countries such as the United States, Spain, Sweden, Switzerland and Iceland recognise this categorisation.
Meanwhile, travellers who aren't fully vaccinated against COVID-19 are required to undergo a pre-departure test and 10-day quarantine at a declared address in Britain.
From Monday, the UK government said it is also simplifying travel rules for all under-18s coming to England from a non-red-list country, who will be treated as fully vaccinated at the border, regardless of their individual vaccination status. This means they will be exempt from self-isolation requirements on arrival and will only be required to take a lateral flow test post-arrival, with a free confirmatory PCR test if they test positive.
While public health is a devolved matter, the government said it is working closely with the devolved administrations of Wales, Scotland and Northern Ireland to ensure a UK-wide approach to the rules.
- wellnessCorbevax Will Be Allowed As A Booster For Those Fully Vaccinated With Covishield Or Covaxin
- kidsCovid-19 Vaccines For Kids: DCGI Grants Emergency Use Nod To 3 Vaccines For Different Age Group Of Children
- wellnessBooster Dose Of COVID Vaccine Needed To Fight Against Omicron: Study
- wellnessIndia's Covaxin To Be Evaluated As COVID-19 Vaccine Candidate In USA
- healthCovaxin Granted Emergency Use Listing In 13 Nations As On Jan 31 According To WHO: Government
- healthEach Dose Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Getting Regular Market Approval
- healthMedia Reports Stating Vaccine Shortage In Maharashtra Are Not Factually Correct: Govt
- healthGovt's Decision On COVID-19 Vaccination For Children 'Unscientific': Senior AIIMS Epidemiologist
- healthCovaxin's Shelf Life Extended To 12 Months From Date Of Manufacture
- healthExperts Allay Covaxin Concerns, Say 50% Effectiveness Against Delta-Driven COVID-19 Surge Not Bad
- healthGovernment Nod To Commercial Export Of Covishield, Covaxin In View Of Sufficient Stock
- healthCovaxin Shows 50% Effectiveness Against Symptomatic Covid-19 In Real-World Assessment: Lancet Study